Christopher B Granger Selected Research

Warfarin (Coumadin)

1/2022	Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial.
1/2022	Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
1/2022	Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial.
1/2021	Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation.
1/2021	Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.
1/2021	Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial.
12/2020	Warfarin for Atrial Fibrillation Stroke Prophylaxis in Advanced Kidney Disease: If You Are Not Confused, You Are Not Thinking Clearly.
1/2020	Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
1/2020	Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
1/2020	Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher B Granger Research Topics

Disease

152	Stroke (Strokes) 01/2022 - 09/2003
150	Atrial Fibrillation 01/2022 - 05/2006
146	Myocardial Infarction 05/2022 - 07/2001
134	ST Elevation Myocardial Infarction 05/2022 - 08/2002
130	Hemorrhage 01/2022 - 10/2002
116	Heart Failure 05/2022 - 01/2002
81	Acute Coronary Syndrome 01/2022 - 07/2001
44	Embolism (Embolus) 01/2022 - 03/2010
35	Infarction (Infarctions) 01/2021 - 07/2002
31	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 06/2002
27	Thrombosis (Thrombus) 05/2022 - 05/2003
20	Hypertension (High Blood Pressure) 01/2022 - 01/2002
19	Shock 05/2022 - 09/2003
18	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2002
17	Inflammation (Inflammations) 05/2022 - 10/2005
13	Heart Arrest (Cardiac Arrest) 06/2022 - 10/2003
13	Unstable Angina 01/2019 - 07/2001
12	Transient Ischemic Attack 01/2022 - 02/2010
11	Out-of-Hospital Cardiac Arrest 06/2022 - 09/2014
10	Ischemia 12/2020 - 03/2005
9	Cardiogenic Shock 03/2020 - 10/2005
9	Body Weight (Weight, Body) 03/2020 - 10/2002
9	Coronary Disease (Coronary Heart Disease) 01/2020 - 09/2006
8	Embolic Stroke 01/2022 - 04/2014
8	Diabetes Mellitus 01/2018 - 02/2004
8	Thrombocytopenia (Thrombopenia) 12/2012 - 02/2005
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 02/2004
7	Myocardial Ischemia (Ischemic Heart Diseases) 09/2016 - 01/2002
7	Hypotension (Low Blood Pressure) 11/2010 - 09/2003
6	Peripheral Arterial Disease 10/2022 - 01/2017
6	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2014
6	Ischemic Stroke 01/2021 - 03/2010
6	Sudden Death 01/2019 - 10/2004
5	Necrosis 01/2022 - 07/2004
5	Thromboembolism 01/2022 - 01/2012
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2010

Drug/Important Bio-Agent (IBA)

90	apixabanIBA 01/2022 - 03/2010
81	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 05/2008
55	AnticoagulantsIBA 01/2022 - 11/2005
52	candesartanIBA 08/2021 - 09/2003
49	Biomarkers (Surrogate Marker)IBA 05/2022 - 08/2002
47	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 02/2002
42	pexelizumabIBA 11/2020 - 09/2003
31	Vitamin K FDA Link 01/2022 - 03/2010
27	Heparin (Liquaemin)FDA LinkGeneric 12/2012 - 02/2002
25	CreatinineIBA 01/2022 - 10/2003
18	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2006
17	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2006
16	Clopidogrel (Plavix)FDA Link 01/2022 - 11/2008
15	Pharmaceutical PreparationsIBA 01/2021 - 09/2003
15	Complement System Proteins (Complement)IBA 09/2013 - 09/2003
14	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 09/2003
14	TroponinIBA 01/2020 - 08/2002
12	Dabigatran FDA Link 01/2022 - 11/2011
12	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 01/2002
12	Fondaparinux (Arixtra)FDA Link 12/2010 - 03/2005
12	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010 - 10/2003
11	Glycoproteins (Glycoprotein)IBA 08/2021 - 06/2002
10	Angiotensin Receptor AntagonistsIBA 01/2022 - 10/2004
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 12/2003
9	MB Form Creatine KinaseIBA 10/2014 - 04/2003
9	Factor Xa InhibitorsIBA 04/2014 - 03/2005
9	Tenecteplase FDA Link 01/2010 - 04/2003
8	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2005
8	Thrombin FDA Link 01/2022 - 03/2005
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 06/2004
7	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2004
7	darapladibIBA 01/2021 - 05/2014
7	omega-Chloroacetophenone (Mace)IBA 01/2020 - 12/2017
7	AntithrombinsIBA 01/2014 - 12/2003
6	Growth Differentiation Factor 15IBA 05/2022 - 11/2014
6	Troponin T (Troponin T1)IBA 01/2022 - 01/2014
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2019
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2005
6	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 03/2005
6	Mineralocorticoid Receptor AntagonistsIBA 08/2021 - 10/2004
6	N(4)-oleylcytosine arabinosideIBA 01/2021 - 09/2014
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 05/2003
6	Eptifibatide (Integrilin)FDA Link 02/2010 - 07/2001
6	paragonIBA 10/2007 - 07/2002
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2006 - 09/2003
5	Cystatin CIBA 01/2022 - 11/2012
5	TicagrelorIBA 01/2022 - 01/2018
5	Irbesartan FDA LinkGeneric 08/2021 - 05/2010
5	Hemoglobins (Hemoglobin)IBA 01/2020 - 02/2006
5	Troponin IIBA 02/2015 - 04/2003
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2011 - 04/2003
5	Streptokinase FDA Link 01/2011 - 07/2002

Therapy/Procedure

153	Therapeutics 10/2022 - 07/2001
127	Percutaneous Coronary Intervention 05/2022 - 08/2003
21	Thrombolytic Therapy 01/2022 - 09/2002
16	Stents 01/2021 - 12/2003
11	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2016 - 03/2005
8	Cardiopulmonary Resuscitation (CPR) 02/2019 - 09/2014
7	Resuscitation 03/2020 - 11/2014
6	Patient Readmission 01/2021 - 11/2009
6	Critical Care (Surgical Intensive Care) 11/2019 - 10/2009
6	Length of Stay 01/2018 - 02/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
5	Blood Transfusion (Blood Transfusions) 05/2015 - 10/2004